Competition aims to redefine regenerative medicine and ensure Toronto and Canada continue to lead the field for decades to come
Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system, paper urges
Data generation, evidence of clinical effectiveness, cost and social values among the key considerations
Weekly webinar series for trainees to cover key concepts in translation and commercialization of regenerative medicine.
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.
'Your research will have a transformational impact on how we treat many common diseases, such as stroke, diabetes and liver failure, creating better health outcomes for all Canadians,' Bains tells annual symposium
Medicine by Design to accelerate regenerative medicine discovery and translation with new $20-million investment
Projects to advance stem cell and gene therapy, enhance understanding of how the body repairs itself, and generate new technologies that will propel the field for decades
A new platform brings together genome editing with magnetic cell sorting to reveal new drug targets for cancer and regenerative medicine
Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only
Toronto investigators part of international team receiving $4-million (U.S.) award from Chan Zuckerberg Initiative
The project, part of the Human Cell Atlas, seeks to build a more complete map of the human liver and is a “direct extension” of the work the Toronto team has already done with support from Medicine by Design
Professor Shulamit Levenberg will serve as Medicine by Design’s first Scholar in Residence from July 15 to August 15, 2019.
International workshop tackles key policy questions around the adoption of regenerative medicine therapies
More than 40 academics, clinicians, policy-makers and industry leaders from Canada and the U.K. participated in the Challenges in the Adoption of Regenerative Medicine Therapies (CHART) workshop on June 24 and 25, 2019.
The competition was the culmination of Medicine by Design’s “Pitching Science” workshop, a six-week long program for graduate students, post-doctoral fellows and research associates
Awards support high-calibre post-doctoral fellows at the University of Toronto and affiliated hospitals who have outstanding potential to become independent researchers in regenerative medicine
Medicine by Design invests $1.2 million in new ideas to advance regenerative medicine research and translation
Nine funded projects span synthetic biology, computational modelling, immunoengineering and organoids
Brown brings to the position more than 14 years of experience at the intersection of research, commercialization and business development.